A new method for improving checkpoint inhibitor therapy for cancer
Checkpoint inhibitor therapies can be thought of as the molecular “brake release” for the immune system. These drugs eliminate the protein barriers that impede the immune system from recognizing and targeting cancer cells in the body. While there are multiple checkpoint inhibitors approved to treat different types of cancer, many patients don’t respond or develop … Read more
/cdn.vox-cdn.com/uploads/chorus_asset/file/24774110/STK156_Instagram_threads_1.jpg)